Publications

5808 Results

Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARa isoform: results from Intergroup protocol 0129

Authors
JL Slack;CL WIllman;JW Andersen;YP Li;DS Viswanatha;CD Bloomfield;MS Tallman;RE Gallagher
Journal / Conference
Blood 95(2):398-403
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

Authors
G Samimi;D Fink;NM Varki;A Husain;WJ Hoskins;DS Alberts;SB Howell
Journal / Conference
Clinical Cancer Research 6:1415-1421
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835

Effects of leucovorin (LV) on the intratumoral (IT) pharmacokinetics (PK) of 5-fluorouracil (5-FU) - a Southwest Oncology Group study

Authors
W Wolf;CA Presant;V Waluch;I Weitz;J Jacobson
Journal / Conference
Proc of the American Association for Cancer Research 41:611(#3885)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006

Spectroscopic evaluation of intratumoral (IT) metabolic modulation (MM) of 5-fluorouracil (5-FU) by leucovorin (LV): Correlation of human tumor pharmacokinetics (PK) with modulation and tumore response. SWOG 9006

Authors
CA Presant;W Wolf;V Waluch;I Weitz;J Jacobson
Journal / Conference
Proc of the American Society of Clinical Oncology 19:194a(#754)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006

Final results from Southwest Oncology Group trial (SWOG) 9705: A phase II trial of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients (PTS) with extensive small cell lung (SCLC).

Authors
K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 19:492a(#1923)
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9705

Prolonged survival in pathologic stage IIIb non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: a phase II study (S9504) of the Southwest Oncology Group (SWOG).

Authors
DR Gandara;LC Lovato; KS Albain;B Leigh;PN Lara;JJ Crowley;K Stelzer;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 19:490a(#1916)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

An economic analsis of Southwest Oncology Group trial S9509: Cisplatin/vinorelbine vs. carboplatin/paclitaxel for advanced nonsmall cell lung cancer

Authors
SD Ramsey;CM Moinpour;LC Lovato;PK Grevstad;K Kelly;C Presant
Journal / Conference
Proc of the American Society of Clinical Oncology 19:489a(#1913)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

A phase III comparison of standard radiation thereapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5FU) in patients with unresectable squamous cell head and neck cancer (SCHNC

Authors
DJ Adelstein;GL Adams;Y Li;H Wagner Jr;JA Kish;JF Ensley;DE Schuller;AA Forastiere
Journal / Conference
Proc of the American Society of Clinical Oncology 19:411a(#1624)
Year
2000
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9059 (E-1392) (INT-0126)

Radiation therapy (RT) alone vs. pre-RT chemotherapy (CTX) for the treatment of primary CNS lymphoma (PCNSL): age matched survival analysis of RTOG-83-15 and RTOG 93-10.

Authors
C Schultz;C Scott;L DeAngelis;D Nelson;C Schold;W Curran
Journal / Conference
Proc of the American Society of Clinical Oncology 19:159a(#617)
Year
2000
Research Committee(s)
Brain
Study Number(s)
SWOG-9310 (INT-0143) (RTOG-93-10)

Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. results of Intergroup study INT-0116 (SWOG 9008)

Authors
JS Macdonald;S Smalley;J Benedetti;N Estes;DG Haller;JA Ajani;LL Gunderson;M Jessup;JA Martenson
Journal / Conference
Proc of the American Society of Clinical Oncology 19:1a(#1)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)